Related Experiment Videos
[Various problems of epidemiology and prevention of suppurative-inflammatory complications in surgery]
Abstract:
An epidemiological analysis of pyo-inflammatory diseases (PID) in surgical department of multiprofile hospitals has been made. PIDs were diagnozed in 16.2% of patients operated upon. The observation of fluctuations of the level of PID with regard for the correlation of severe and "minor" forms and terms of their appearance allows to make a conclusion of the probable place of infection and may serve an indicator of epidemiological situation. The application of film-forming drug "Lyfuzol" for closing operative wounds has decreased the incidence of PID in catarrhal and phlegmonous appendicitis 2.6 times.
Insights
Pyogenic-inflammatory diseases (PID) affect 16.2% of surgical patients. A new wound closure drug, Lyfuzol, reduced PID incidence by 2.6 times in appendicitis cases.
Area of Science:
- Epidemiology
- Surgical Infections
- Infectious Disease
Context:
- Pyogenic-inflammatory diseases (PID) represent a significant complication in surgical patients.
- Understanding PID incidence and patterns is crucial for hospital infection control.
- Multiprofile hospitals manage a diverse range of surgical cases, making them ideal for epidemiological studies.
Purpose:
- To analyze the incidence and patterns of pyogenic-inflammatory diseases (PID) in a surgical department.
- To investigate the correlation between PID severity, onset timing, and potential infection sources.
- To evaluate the efficacy of the film-forming drug "Lyfuzol" in reducing postoperative PID.
Summary:
- An epidemiological analysis identified pyogenic-inflammatory diseases (PID) in 16.2% of operated patients.
- PID fluctuations and disease forms correlate with infection sources, serving as epidemiological indicators.
- The film-forming drug "Lyfuzol" decreased PID incidence by 2.6 times in catarrhal and phlegmonous appendicitis.
Impact:
- The study provides insights into the epidemiology of surgical site infections.
- Lyfuzol demonstrates potential as an effective measure to reduce postoperative complications.
- Findings can inform infection control strategies and improve patient outcomes in surgical settings.